{
    "Trade/Device Name(s)": [
        "Cholinesterase Gen.2 Test System",
        "Cholinesterase Gen.2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K061093",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951595"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIH"
    ],
    "Summary Letter Date": "July 3, 2006",
    "Summary Letter Received Date": "April 19, 2006",
    "Submission Date": "April 18, 2006",
    "Regulation Number(s)": [
        "21CFR862.3240"
    ],
    "Regulation Name(s)": [
        "Cholinesterase test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholinesterase"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "COBAS Integra family of analyzers",
        "Integra 400",
        "Integra 700",
        "Integra 800"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric detection",
        "Butyrylthiocholine method"
    ],
    "Methodologies": [
        "Enzymatic activity measurement"
    ],
    "Submission Type(s)": [
        "Test System",
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Cholinesterase Gen.2 spectrophotometric enzymatic assay to measure cholinesterase activity in serum and plasma",
    "Indications for Use Summary": "In vitro quantitative determination of cholinesterase catalytic activity in serum and plasma for diagnosis and treatment of cholinesterase inhibition disorders",
    "fda_folder": "Toxicology"
}